Rezolute (RZLT) Interest Coverage Ratio (QoQ) (2012 - 2019)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Rezolute | 374.41 Mn | 374.41 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2019 | 74.34% |
| Mar 31, 2019 | -17.66% |
| Dec 31, 2018 | 12.73% |
| Sep 30, 2018 | 84.20% |
| Jun 30, 2018 | 80.82% |
| Mar 31, 2018 | 99.76% |
| Sep 30, 2016 | 44.00% |
| Jun 30, 2016 | -31.69% |
| Mar 31, 2016 | -10.23% |
| Dec 31, 2015 | -44.15% |
| Sep 30, 2015 | -21.94% |
| Jun 30, 2015 | -52.14% |
| Mar 31, 2015 | 17.40% |
| Dec 31, 2014 | 70.14% |
| Sep 30, 2014 | -0.24% |
| Jun 30, 2014 | -961,858.42% |
| Mar 31, 2014 | 55.55% |
| Dec 31, 2013 | 75.48% |
| Sep 30, 2013 | 27.52% |
| Jun 30, 2013 | 73.70% |
| Mar 31, 2013 | -388.23% |
| Dec 31, 2012 | 11.69% |
| Sep 30, 2012 | -342.24% |
| Jun 30, 2012 | -13.49% |